14 Results for "

Soluble Guanylyl Cyclase

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "Soluble Guanylyl Cyclase" in MCE Product Catalog:

36
36 Publications Verification
Cat. No.: HY-14927
CAS No.: 170632-47-0
Purity:  99.70%
Synonyms: YC-1
Target:  

Guanylate Cyclase

Research Areas:  

Cardiovascular Disease Cancer

Lificiguat binds to the β subunit of soluble guanylyl cyclase(sGC) with Kd of 0.6-1.1 μM in the presence of CO.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-101255
CAS No.: 41443-28-1
Purity:  99.75%
Research Areas:  

Cancer

ODQ is a potent and selective soluble guanylyl cyclase (sGC, nitric oxide-activated enzyme) inhibitor. ODQ enhances the pro-apoptotic effects of Cisplatin in human mesothelioma cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12379
CAS No.: 204326-43-2
Purity:  99.58%
Target:  

Guanylate Cyclase

Research Areas:  

Inflammation/Immunology

NS-2028 is a highly selective soluble Guanylyl Cyclase (sGC) inhibitor with IC50 values of 30 nM and 200 nM for basal and NO-stimulated enzyme activity . NS-2028 inhibits soluble Guanylyl Cyclase activity in homogenates of mouse cerebellum and neuronal NO synthase with IC50 values of 17 nM and 20 nM . NS-2028 inhibits 3-morpholino-sydnonimine (SIN-1)-elicited formation of cyclic GMP in human cultured umbilical vein endothelial cells with an IC50 of 30 nM . NS-2028 is commonly used in the research of nitric oxide signaling pathways, it inhibits NO-dependent relaxant responses in non-vascular smooth muscle completely (1 μM) . NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability .
loading...
    loading...
Cat. No.: HY-113926
CAS No.: 1027642-43-8
Purity:  98.15%
Target:  

Guanylate Cyclase

Research Areas:  

Cardiovascular Disease

BAY 60-2770 is a potent, selective, and orally active soluble guanylyl cyclase (sGC) activator. BAY 60-2770 increases the activity of sGC in a nitric oxide-independent manner. BAY 60-2770 shows antifibrotic effect .
loading...
    loading...
Cat. No.: HY-W062836
CAS No.: 256498-66-5
Target:  

Guanylate Cyclase

Research Areas:  

Cardiovascular Disease

BAY 41-8543 is an orally active, nitric oxide (NO)-independent stimulator of soluble guanylyl cyclase (sGC). BAY 41-8543 has vasodilator activity in the pulmonary and systemic vascular beds in the rat. BAY 41-8543 has antiplatelet effects and has the potential for cardiovascular diseases research .
loading...
    loading...
Cat. No.: HY-178191
sGC stimulator 1 is a carbonyl sulfide (COS)/H2S-donor hybrid soluble guanylyl cyclase (sGC) stimulator (EC50 = 496 nM). sGC stimulator 1 exhibits a well-characterized H2S-releasing property. sGC stimulator 1 reduces fibrosis in TGF-β1-treated cardiac fibroblasts by increasing cGMP and H2S levels. sGC stimulator 1 can exert anti-fibrotic effects by activating sGC and increasing H2S. sGC stimulator 1 can be used for the study of heart failure (HF) .
loading...
    loading...
Cat. No.: HY-129088
CAS No.: 312747-21-0
Purity:  99.68%
Research Areas:  

Cardiovascular Disease

HUP30 is a vasodilating agent. HUP30 stimulates soluble guanylyl cyclase, activate K + channels, and blocks extracellular Ca 2+ influx .
loading...
    loading...
Cat. No.: HY-14927R
CAS No.: 170632-47-0
Synonyms: YC-1 (Standard)
Lificiguat (Standard) is the analytical standard of Lificiguat. This product is intended for research and analytical applications. Lificiguat binds to the β subunit of soluble guanylyl cyclase(sGC) with Kd of 0.6-1.1 μM in the presence of CO.
loading...
    loading...
Cat. No.: HY-117962
CAS No.: 1423067-48-4
Target:  

Guanylate Cyclase

Research Areas:  

Metabolic Disease

(Rac)-BI 703704 is a potent soluble guanylyl cyclase (sGC) activator. (Rac)-BI 703704 reduces progression of renal damage in the ZSF1 rat, and highlight the potential of sGC activation as an effective therapy for diabetic nephropathy .
loading...
    loading...
Cat. No.: HY-101255R
CAS No.: 41443-28-1
Research Areas:  

Cancer

ODQ (Standard) is the analytical standard of ODQ. This product is intended for research and analytical applications. ODQ is a potent and selective soluble guanylyl cyclase (sGC, nitric oxide-activated enzyme) inhibitor. ODQ enhances the pro-apoptotic effects of Cisplatin in human mesothelioma cells .
loading...
    loading...
Cat. No.: HY-129670
CAS No.: 81996-46-5
KMUP-1 is a xanthine derivative with vasodilator activity. KMUP-1 is a inhibitor of phosphodiesterase (PDE) and activator of soluble guanylyl cyclase (sGC). KMUP-1 stimulates NO/sGC/cyclic GMP pathway. KMUP-1 has K + channels opening activity. KMUP-1 ameliorates ischemia-induced cardiomyocyte apoptosis. KMUP-1 can be used for cardiovascular and anti-inflammatory study .
loading...
    loading...
Cat. No.: HY-135451
CAS No.: 268725-86-6
Research Areas:  

Cardiovascular Disease

CFM 1571 is a soluble guanylyl cyclase (sGC) activator with an IC50 of ~5.5 μM. CFM 1571 activates sGC in a NO-independent manner and exerts a synergistic effect with NO. CFM 1571 inhibits platelet aggregation .
loading...
    loading...
Cat. No.: HY-187209
CAS No.: 1350852-88-8
SGC stimulator 2 is an orally active soluble guanylyl cyclase (sGC) stimulator with an EC50 of 44 nM. SGC stimulator 2 exhibits inhibitory activity against the CB2 receptor, with an IC50 of 2.7 μM. SGC stimulator 2 activates native (Fe 2+) sGC in a heme-dependent manner. SGC stimulator 2 produces sustained hypotensive effects in animal models. SGC stimulator 2 can be used for the research of hypertension .
loading...
    loading...
Cat. No.: HY-137609A
Synonyms: TNP-Guanosine 5'-triphosphate tetrasodium
TNP-GTP tetrasodium is a fluorescently labeled GTP (HY-113225) derivative. TNP-GTP tetrasodium can inhibit glutamate dehydrogenase (Ki = 2.7 μM). TNP-GTP tetrasodium is an antagonist of the purinergic P2X2 and P2X2/3 receptors with IC50 values of 0.4 and 1.2 nM, respectively. TNP-GTP tetrasodium also inhibit rat soluble guanylyl cyclase (Ki = 11 nM) .
loading...
    loading...
  • 1